Our findings revealed that digoxin treatment inhibited the upregulation of MMP-13 and ADAMTS4/5 induced by TNF-α, leading to restoration of the expression of Col-2 and Aggrecan, indicating its potential role in inhibiting ECM degradation in disc degeneration. This evidence concerns the gene ACAN and intervertebral disk degenerative disorder.